VYNE hosts KOL event to update on BET inhibitor platform and VYN201

VYNE Therapeutics Inc.

Virtual KOL event held May 17, 2022 on InhiBET platform and VYN201.
Presentation attached as Exhibit 99.1 and available on company website.
No specific clinical data or financial results disclosed in the filing.

item 7.01 item 9.01

VYNE Therapeutics Inc. filing history →

Source: SEC EDGAR

accession 0001104659-22-061796

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.